Rating History for RayzeBio (RYZB) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/28/2023 | Jessica Fye | Downgrade | Neutral (Overweight) |
62.50 (30.00) |
61.40 (62.49) |
1.78% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/28/2023 | Jessica Fye | Downgrade | Neutral (Overweight) |
62.50 (30.00) |
61.40 (62.49) |
1.78% | Details |
![]() |
|||||||